Skip to main content

Maze Therapeutics Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Maze Therapeutics Inc

Current Price

$25.56

-3.29%
Profile
Valuation (TTM)
Market Cap$1.27B
P/E-10.37
EV
P/B3.58
Shares Out49.71M
P/Sales63.53
Revenue$20.00M
EV/EBITDA

Maze Therapeutics Inc (MAZE) Dividends

Dividend Overview

Dividend Yield

Dividend / Share

Key Metrics

Market Cap

$1.27B

P/E Ratio

-10.37

Forward P/E

EPS

$-3.05

PEG Ratio

0.17

Book Value

$7.14

Dividend Yield

Profit Margin

-612.71%

ROE

-34.52%

Dividend History

Dividend Safety

MAZE Dividend Analysis

Maze Therapeutics Inc (MAZE) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -10.37. Profit margin: -612.71%. Free cash flow: $-112.73M. This page shows Maze Therapeutics Inc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Maze Therapeutics Inc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.